mitoquinone

Small moleculeexperimental

Clinical trial activity

7 trials · 12 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Mar 1, 2007 (NCT00433108)

Timeline

2000s

  1. Jan 1, 2007

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2017

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetAntioxidant

    antioxidant

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • mito-q
  • mitoquinone
  • mitoquinone
  • mitoquinone
  • mitoquinone
  • mitoquinone mesylate
  • mitoquinone mesylate

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07244809N/AOct 13, 2025University of Iowa
NCT06784531N/ASep 16, 2024United States Army
NCT05373043N/ANov 1, 2022Department of Veteran Affairs
NCT05146843N/ADec 2, 2021D'Or Institute for Research and Education, Hospital São Luiz, Instituto do Cancer do Estado de São Paulo, University of Sao Paulo
NCT03166800Phase 1/Phase 2 (Phase 2)May 1, 2017MitoQ Ltd, Oregon Health and Science University
NCT01167088Phase 2Nov 1, 2010Antipodean Pharmaceuticals, Inc., Newcastle University
NCT00433108Phase 2Mar 1, 2007Antipodean Pharmaceuticals, Inc., University of Auckland
Showing 7 of 7 trials
Page 1 / 1

Organizations

Research & Development (12)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Antipodean Pharmaceuticals, Inc.For profit2212007
Department of Veteran AffairsGovernment1112022
D'Or Institute for Research and EducationAcademic/Hospital1112021
Hospital São LuizAcademic/Hospital1012021
Instituto do Cancer do Estado de São PauloAcademic/Hospital1012021
MitoQ LtdFor profit1012017
Newcastle UniversityAcademic/Hospital1012010
Oregon Health and Science UniversityAcademic/Hospital1112017
United States ArmyGovernment1112024
University of AucklandAcademic/Hospital1012007
University of IowaAcademic/Hospital1112025
University of Sao PauloAcademic/Hospital1012021
12 organizations
Page 1 / 1